Showing 24 out of 34 results
Climate change: succeed in a net-zero future
The risks associated with climate change go way beyond the purely environmental.In our climate change briefing we consider at a high level the political, …
Herbert Smith Freehills advises sponsors on Abbisko’s HK$1.754 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为和誉开曼17.54亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and J.P. Morgan as joint sponsors of biopharmaceutical company Abbisko Cayman …
Herbert Smith Freehills advises sponsors on Brii Biosciences’ HK$2.483 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为腾盛博药24.83亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and UBS as joint sponsors of biopharmaceutical company Brii Biosciences …
Herbert Smith Freehills advises sponsors on CARsgen Therapeutics’ HK$3.1 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为科济药业31亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics …
Asia Pacific M&A Review 2021
Our eighth annual review of Asia's deal scene assesses the outlook for big-ticket M&A after a turbulent but eventful yearChange is the only constant …
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …
Herbert Smith Freehills advises sponsors on Simcere Pharmaceutical’s HK$3.57 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为先声药业35.7亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities …
Digihealth and the dash for data – The key legal issues
As Big Pharma meets Big Tech, demand for health data has exploded. We steer you through the rocky ethical and regulatory terrainThe healthcare and …
Can predictive analytics prevent employee misconduct?
The appeal of data tools in unearthing misconduct is clear. So are the risks if employers fail to tread carefullyWith predictive policing and crime …
Digital forensics in investigations and the growing data burden
Businesses will need smarter data collection and management strategies to satisfy regulators The approach to digital forensics in investigations is …
Using big data to fight financial crime
In a regulatory environment which demands ever higher standards for anti-money laundering (AML) compliance, many financial institutions have responded by …
Showing 24 out of 34 results
View more